This inventor holds 4 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent. Top assignee: Janssen Biotech, Inc.. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: Kim Hung Lo: Innovator in Anti-TNF Antibody Treatments
Introduction
Kim Hung Lo is a notable inventor based in Exton, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of treatments for autoimmune diseases. With a total of 4 patents to his name, his work has the potential to impact many lives.
Latest Patents
Among his latest patents are innovative compositions and methods utilizing anti-TNF antibodies. One of his notable inventions focuses on the treatment of active Ankylosing Spondylitis. This invention relates to compositions and methods that utilize anti-TNF antibodies with a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37. This formulation aims to provide a safe and effective treatment for individuals suffering from active Ankylosing Spondylitis (AS). Another patent addresses the treatment of active Psoriatic Arthritis (PsA) using similar anti-TNF antibodies.
Career Highlights
Kim Hung Lo is currently associated with Janssen Biotech, Inc., where he continues to innovate in the field of biotechnology. His work is characterized by a commitment to developing effective therapies for chronic inflammatory conditions.
Collaborations
He collaborates with esteemed colleagues, including Diane Deborah Harrison and Elizabeth C Hsia, to advance research and development in his field.
Conclusion
Kim Hung Lo's contributions to the development of anti-TNF antibody treatments highlight his role as a significant inventor in biotechnology. His innovative work continues to pave the way for new therapeutic options for patients with autoimmune diseases.